<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the efficacy of Yizhi capsule (YZC) in treating senile <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Sixty-one vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) patients were randomly divided into YZC and control groups </plain></SENT>
<SENT sid="2" pm="."><plain>There were 32 cases in YZC group, 4 capsules each time three times a day </plain></SENT>
<SENT sid="3" pm="."><plain>In control group, there were 29 cases, 2 mg of hydergine were given each time three times a day, single-blind method was used and the treatment course was two months </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: YZC could remarkably increase mini-mental state examination (MMSE) and Hamilton <z:hpo ids='HP_0000716'>Depression</z:hpo> Scale (HDS) marks of VaD patients </plain></SENT>
<SENT sid="5" pm="."><plain>YZC had the effect of improving balance and gait ability of VaD patients </plain></SENT>
<SENT sid="6" pm="."><plain>YZC could improve the abnormal blood velocity (BV), as well as improve cerebral blood flow, brain electrical activity monitoring (BEAM) and hemorheological indexes especially for the abnormal case </plain></SENT>
<SENT sid="7" pm="."><plain>No side-effect or toxic-effect was observed in the administration period </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: YZC had certain effect on senile VaD, and it was safe in application </plain></SENT>
</text></document>